<DOC>
	<DOCNO>NCT01429311</DOCNO>
	<brief_summary>Atopic dermatitis ( AD ) chronic skin disorder characterize recurrent viral skin infection . A small subset patient AD suffer disseminate viral infection , e.g. , eczema herpeticum ( ADEH+ ) , herpes simplex infection ( HSV ) eczema vaccinatum ( EV ) smallpox vaccination . Interferon gamma ( IFNγ ) play critical role innate acquire immune response activate macrophage , enhance natural killer cell activation , promote T cell differentiation , well regulate B cell isotype switch immunoglobulin ( Ig ) G2a . Recent study demonstrate IFNγ generation significantly decrease stimulation HSV ex vivo . The purpose study determine deficient IFNγ induction lead susceptibility HSV infection ADEH+ patient .</brief_summary>
	<brief_title>Interferon Responses Eczema Herpeticum</brief_title>
	<detailed_description>The investigator hypothesize defective IFNγ responses peripheral blood mononuclear cell ( PBMCs ) ADEH+ patient result aberrant pattern recognition receptor ( PRR ) signal antigen-presenting cell ( APCs ) result low level production IL-12 , essential cytokine IFNγ generation . This study compare result 40 ADEH+ , 40 ADEH- , 40 non-atopic participant . Study procedures typically complete one visit ; however , participant may ask return additional unscheduled visit ( ) occur frequently every 3 month duration study provide additional blood sample characterization immune mechanism lead reduce IFNγ responses ADEH+ .</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Herpes Simplex</mesh_term>
	<mesh_term>Kaposi Varicelliform Eruption</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<criteria>Participant Participants meet follow criterion eligible enrollment : history AD without history Eczema Herpeticum ( EH ) diagnose use Atopic Dermatitis Research Network ( ADRN ) Standard Diagnostic Criteria OR nonatopic diagnose use ADRN Standard Diagnostic Criteria willing sign inform consent form whose parent legal guardian willing sign inform consent form ( age appropriate ) prior initiation study procedure willing sign assent form , age appropriate . Participant Participants meet follow criterion eligible enrollment : history systemic illness ( e.g. , immunodeficiency disorder human immunodeficiency virus [ HIV ] lupus erythematosus ) condition study active systemic malignancy , exclude uncomplicated nonmelanoma skin cancer skin disease AD might compromise stratum corneum barrier ( e.g. , bullous disease , psoriasis , cutaneous T cell lymphoma [ also call Mycosis Fungoides Sezary syndrome ] , dermatitis herpetiformis , HaileyHailey , Darier 's disease ) first degree relative already enrol study determine eligible opinion Investigator . Participants meet follow criterion eligible enrollment may reassess : active eczema herpeticum Enrollment Visit take systemic immunosuppressive drug include cyclosporine oral steroid within 30 day Enrollment Visit fever &gt; /= 38.5 ºC ( 101.3 ºF ) Enrollment Visit .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Atopic Dermatitis</keyword>
	<keyword>Eczema herpeticum</keyword>
	<keyword>Interferon gamma</keyword>
	<keyword>IFNγ</keyword>
</DOC>